Fenofibrate-induced rhabdomyolysis in a patient with chronic kidney disease: an unusual presenting feature of hypothyroidism;Rabdomiólise induzida por fenofibrato em paciente com doença renal crônica: Uma apresentação clínica incomum do hipotireoidismo

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 53, Issue 3, 2009, Pages 383-386

  de Sousa, Alessandra Alves ^a   Kronit, Hans Stauber ^a   Neves, Francisco de Assis Rocha ^b   Amato, Angélica Amorim ^b  

^a Sociedade de Clínica Médica Soclimed   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Chronic kidney disease; Fibrate; Hypothyroidism; Rhabdomyolysis

Indexed keywords

EID: 68349090268     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302009000300015     Document Type: Article

References (37)

1. Cakir M, Samanci N, Balci N, Balci MK. Musculoskeletal manifestations in patients with thyroid disease. Clin Endocrinol. 2003;59(2):162-7.
2. White GH, Walmsley RN. Plasma enzyme activities in primary hypothyroidism. Clin Chem. 1984;30(2):323-5.
3. Benvenga S, Toscano A, Rodolico C, Vita G, Trimarchi F. Endocrine evaluation for muscle pain. J R Soc Med. 2001;94(8):405-7.
4. Sekine N, Yamamoto M, Michikawa M, Enomoto T, Hayashi M, Ozawa E, et al. Rhabdomyolysis and acute renal failure in a patient with hypothyrodism. Int Med. 1993;32(3):269-71.
5. Soltani P, Rezvanfar MR, Pirasteh S. Acute renal failure in a patient with Sheehan Syndrome and rhabdomyolysis. IJKD. 2008;2(1):50-2.
6. Miller ML, Rubin DI. Hypothyroid myopathy. UpToDate [serial on the Internet]. 2007 Dec [cited 2009 Jan 5]. Available from: http://www.uptodate.com/online/content/topic.do?topicKey=medneuro/8565 &selectedTitle=13&source=search_result
7. Clouâtre Y, Leblane M, Ouimet D, Pichette V. Fenofibrate-induced rhabdomyolysis in two dialysis patients with hypothyroidism. Nephrol Dial Transplantat. 1999;14(4):1047-8.
8. Bhansali A, Chandran V, Ramesh J, Kashyap A, Dash RJ. Acute myoedema: an unusual presenting manifestation of hypothyroid myopathy. Postgrad Med J. 2000;76(892):99-100.
9. Huerta-Alardin AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis--an overview for clinicians. Crit Care. 2005;9(2):158-69.
10. Warren JD, Blumbergs PC, Thompson PD. Rhabdomyolysis: a review. Muscle Nerve. 2002;25(3):332-47.
11. Polderman KH. Acute renal failure and rhabdomyolysis. Int J Artif Organs. 2004;27(12):1030-3.
12. Sauret J, Marinides G, Wang G. Rhabdomyolysis. Am Fam Phys. 2002;65(5):907-12.
13. Bagley WH, Yang H, Shah KH. Rhabdomyolysis. Intern Emerg Med. 2007;2(3):210-8.
14. Freeston J, Gough A. Reversible myopathy and renal impairment. J R Soc Med. 2004;97(3):124-5.
15. Mazokipakis EE. Unusual causes of rhabdomyolysis. Intern Med J. 2008;38(5):364-7.
16. Galli-Tsinopoulou A, Stylianou C, Kokka P, Panagopoulou P, Nousia-Arvanitakis S. Rhabdomyolysis, renal failure, pericardial effusion, and acquired von Willebrand disease resulting from hypothyroidism in a 10-year-old girl. Thyroid. 2008;18(3):373-5.
17. Nelson SR, Phillips AO, Hendry BM. Hypothyroidism and rhabdomyolysis in a marathon runner. Nephrol Dial Transplant. 1993;8(4):375-6.
18. Vold PL, Weiss PJ. Rhabdomyolysis from tourniquet trauma in a patient with hypothyroidism. West J of Med. 1995;162(3):270-2.
19. Satarasinghe RL, Ramesh R, Riyaaz AA, Gunarathne PA, de Silva AP. Hypothyroidism is a predisposing factor for fenofibrate-induced rhabdomyolysis--patient report and literature review. Drug Metabol and Drug Interact. 2007;22(4):279-83.
20. Kisakol G, Tunc R, Kaya A. Rhabdomyolysis in a patient with hypothyroidism. Endocr J. 2003;50(2):221-3.
21. Grahan DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade LL, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA. 2004;292(21):2585-90.
22. Rabhi M, Chaari J, Toloune F. Rhabdomyolysis disclosing hypothyroidism. Eur J Int Med. 2006;17(3):220.
23. Argov Z, Renshaw PF, Boden B, Winkokur A, Bank WJ. Effects of thyroid hormones on skeletal muscle bioenergetics. In vivo phosphorus-31 magnetic resonance spectroscopy study of humans and rats. J Clin Invest. 1988;81(6):1695-701.
24. Siciliano G, Monzani F, Manca ML, Tessa A, Caraccio N, Tozzi G, et al. Human mitochondrial transcription factor A reduction and mitochondrial dysfunction in Hashimoto's hypothyroid myopathy. Mol Med. 2002;8(6):326-33.
25. Larsson NG, Wang J, Wilhelmsson H, Oldfors A, Rustin P, Lewandoski M, et al. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet. 1998;18(3):231-36.
26. Bar SL, Holmes DT, Frohlich J. Asymptomatic hypothyroidism and statin-induced myopathy. Can Fam Physician. 2007;53(3):428-31.
27. Barahona MJ, Mauri A, Sucunza N, Paredes R, Wägner AM. Hypothyroidism as a cause of rhabdomyolysis. Endocr J. 2002;49(6):621-3.
28. Tahmaz M, Kumbasar B, Ergen K, Ure U, Karatemiz G, Kazancioglu R. Acute renal failure secondary to fenofibrato monotherapyinduced rhabdomyolysis. Ren Fail. 2007;29(8):927-30.
29. Altay M, Duranay M, Ceri M. Rhabdomyolysis due to hypothyroidism. Nephrol Dial Transplant. 2005;20(4):847-8.
30. Birewar S, Oppenheimer M, Zawada ET. Hypothyroid acute renal failure. S D J Med. 2004;57(3):109-10.
31. Qari FA. Severe rhabdomyolysis and acute renal failure secondary to use of simvastatin in undiagnosed hypothyroidism. Saudi J Kidney Dis Transplant. 2009;20(1):127-9.
32. Kiernan TJ, Rochford M, McDermott JH. Simvastatin induced rhabdomyolysis and an important clinical link with hypothyroidism. Int J Cardiol. 2007;119(3):374-6.
33. Yeter E, Keles T, Durmaz T, Bozkurt E. Rhabdomyolysis due to the additive effect of statin therapy and hypothyroidism: a case report. J Med Case Reports. 2007;1:130.
34. Al-Jubouri MA, Briston PG, Sinclair D, Chinn RH, Young RM. Lesson of the week: myxoedema revealed by simvastatin induced myopathy. BMJ. 1994;308(6928):588.
35. Tokinaga K, Oeda T, Suzuki Y, Matsushima Y. HMG-CoA reductase inhibitors (statins) might cause high elevations of creatinine phosphokinase (CK) in patients with unnoticed hypothyroidism. Endocr J. 2006;53(3):401-5.
36. Olukoga AO, Crowley VEF, Lawal A, Weinkove C. Hyperlipidaemia and hypothyroidism. Screen patients for hypothyroidism before treatment. BMJ. 1994;308(6933):918.
37. Kisch E, Segall HS. Interaction between simvastatin and L-thyroxin. Ann Int Med. 2005;143(7):547.